These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35911185)

  • 1. The role of exercise right heart catheterization to guide pulmonary hypertension therapy in older adults.
    Mak S; Kolker S; Girdharry NR; Bentley RF; Valle FH; Gurtu V; Mok KH; Moric J; Thenganatt J; Granton JT
    Pulm Circ; 2022 Jul; 12(3):e12103. PubMed ID: 35911185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphodiesterase 5 inhibitors for pulmonary hypertension.
    Barnes H; Brown Z; Burns A; Williams T
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD012621. PubMed ID: 30701543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left Heart Disease Phenotype in Elderly Patients with Pulmonary Arterial Hypertension: Insights from the Italian PATRIARCA Registry.
    Toma M; Miceli R; Bonsante E; Colombo D; Confalonieri M; Garascia A; Ghio S; Lattanzio M; Lombardi CM; Paciocco G; Piccinino C; Rota I; Santolamazza C; Scelsi L; Scuri P; Stolfo D; Vincenzi A; Volpiano L; Vicenzi M; Ameri P
    J Clin Med; 2022 Nov; 11(23):. PubMed ID: 36498710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ventilatory power, a cardiopulmonary exercise testing parameter for the prediction of pulmonary hypertension at right heart catheterization.
    Correale M; Monaco I; Ferraretti A; Tricarico L; Sicuranza M; Gallotta AM; Formica ES; Acanfora G; Di Biase M; Brunetti ND
    Int J Cardiol Heart Vasc; 2020 Jun; 28():100513. PubMed ID: 32346602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics of pulmonary hypertension patients who underwent right heart catheterization in Thailand: 5-year retrospective single-centre study.
    Chiansirikraivuti N; Sapankaew T; Pirompanich P
    Lung India; 2023; 40(1):42-47. PubMed ID: 36695258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experience with exercise right heart catheterization in the diagnosis of pulmonary hypertension: a retrospective study.
    Keusch S; Bucher A; Müller-Mottet S; Hasler E; Maggiorini M; Speich R; Ulrich S
    Multidiscip Respir Med; 2014; 9(1):51. PubMed ID: 25352986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left heart disease: a frequent cause of early pulmonary hypertension in systemic sclerosis, unrelated to elevated NT-proBNP levels or overt cardiac fibrosis but associated with increased levels of MR-proANP and MR-proADM: retrospective analysis of a French Canadian cohort.
    Miller L; Chartrand S; Koenig M; Goulet JR; Rich É; Chin AS; Chartrand-Lefebvre C; Abrahamowicz M; Senécal JL; Grodzicky T
    Scand J Rheumatol; 2014; 43(4):314-23. PubMed ID: 25089008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of cardiopulmonary exercise test in early diagnosis of pulmonary hypertension in scleroderma patients.
    Sánchez-Aguilera Sánchez-Paulete P; Lázaro Salvador M; Berenguel Senén A; Méndez Perles C; Rodríguez Padial L
    Med Clin (Barc); 2023 Apr; 160(7):283-288. PubMed ID: 36049974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Right heart catheterization measuring central hemodynamics in cystic fibrosis during exercise.
    Hayes D; Daniels CJ; Mansour HM; Kopp BT; Yates AR; McCoy KS; Patel AV; Kirkby S
    Respir Med; 2013 Sep; 107(9):1365-9. PubMed ID: 23830093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Right Heart Adaptation to Exercise in Pulmonary Hypertension: An Invasive Hemodynamic Study.
    Baratto C; Caravita S; Dewachter C; Faini A; Perego GB; Bondue A; Senni M; Muraru D; Badano LP; Parati G; Vachiéry JL
    J Card Fail; 2023 Sep; 29(9):1261-1272. PubMed ID: 37150503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Left Heart Disease Risk Factors on Outcomes in Pulmonary Arterial Hypertension Therapy.
    Kearney K; Brown K; Celermajer DS; Collins N; Cordina R; Corrigan C; Dwyer N; Feenstra J; Keating D; Keogh A; Kotlyar E; Lavender M; McWilliams T; Williams T; Whitford H; Weintraub R; Wrobel J; Ellender C; Anderson J; Lau EM;
    Chest; 2024 Apr; 165(4):967-977. PubMed ID: 37951349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Underrated value of repeated right heart catheterization in pulmonary hypertension with heart failure-a case of persisted pulmonary arterial hypertension after treatment for biventricular failure.
    Park S; Yoon HY; Jeung S; Lee NK; Kim MS; Ahn JM; Kim DH; Lee JS
    J Thorac Dis; 2015 Oct; 7(10):E489-92. PubMed ID: 26623126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Right Heart Catheterization (RHC): A Comprehensive Review of Provocation Tests and Hepatic Hemodynamics in Patients With Pulmonary Hypertension (PH).
    Gonzalez-Hermosillo LM; Cueto-Robledo G; Roldan-Valadez E; Graniel-Palafox LE; Garcia-Cesar M; Torres-Rojas MB; Romero-Martinez B; Castro-Escalante KY
    Curr Probl Cardiol; 2022 Dec; 47(12):101351. PubMed ID: 35948196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Value of Follow-Up Hemodynamic Variables After Initial Management in Pulmonary Arterial Hypertension.
    Weatherald J; Boucly A; Chemla D; Savale L; Peng M; Jevnikar M; Jaïs X; Taniguchi Y; O'Connell C; Parent F; Sattler C; Hervé P; Simonneau G; Montani D; Humbert M; Adir Y; Sitbon O
    Circulation; 2018 Feb; 137(7):693-704. PubMed ID: 29070502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular magnetic resonance-guided right heart catheterization in a conventional CMR environment - predictors of procedure success and duration in pulmonary artery hypertension.
    Knight DS; Kotecha T; Martinez-Naharro A; Brown JT; Bertelli M; Fontana M; Muthurangu V; Coghlan JG
    J Cardiovasc Magn Reson; 2019 Sep; 21(1):57. PubMed ID: 31495338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Lung Glucose Uptake with Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/CT in Patients with Pulmonary Arterial Hypertension and Pulmonary Hypertension Due to Left Heart Disease.
    Ohira H; deKemp R; Kadoya Y; Renaud J; Stewart DJ; Davies RA; Chandy G; Contreras-Dominguez V; Pugliese C; Dunne R; Beanlands R; Mielniczuk L
    Ann Nucl Cardiol; 2022; 8(1):21-29. PubMed ID: 36540173
    [No Abstract]   [Full Text] [Related]  

  • 17. Hemodynamics in pulmonary arterial hypertension: current and future perspectives.
    Saggar R; Sitbon O
    Am J Cardiol; 2012 Sep; 110(6 Suppl):9S-15S. PubMed ID: 22921033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiopulmonary exercise test predicts right heart catheterization.
    Correale M; Tricarico L; Ferraretti A; Monaco I; Concilio M; Padovano G; Acanfora G; Di Biase M; Brunetti ND
    Eur J Clin Invest; 2017 Dec; 47(12):. PubMed ID: 29082512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Classification, diagnosis and treatment status of pulmonary hypertension from 2012 to 2019: a single center study in Yunnan province].
    Feng XL; Lu YB; Yang D; Xue Q; Zhang JL; Lin CR; Gan P; Zhang WH; Guang XF; Dai HL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2023 Nov; 51(11):1188-1193. PubMed ID: 37963755
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term pulmonary hemodynamic effects of ambrisentan in pulmonary arterial hypertension.
    Klinger JR; Oudiz RJ; Spence R; Despain D; Dufton C
    Am J Cardiol; 2011 Jul; 108(2):302-7. PubMed ID: 21545989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.